Alcaftadine
阿卡他定
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameAlcaftadine
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2010/07/28
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesVistakon
China Registration ClassN/A
Develop Information
Active CompaniesAllergan Plc
Inactive CompaniesVistakon Pharmaceuticals Llc
Active Indications
Inactive IndicationsN/A